In the rapidly evolving world of MedTech, the convergence of Artificial Intelligence (AI) and Software as a Medical Device (SaMD) is revolutionizing how healthcare solutions are designed, delivered, and regulated. At MDx CRO, we help developers of AI-powered SaMD navigate complex clinical and regulatory pathways with confidence and precision.
Why It Matters:
AI-based diagnostic tools, decision support systems, and therapeutic algorithms promise faster, more accurate patient care. But these innovative technologies bring unique regulatory, clinical, and usability challenges—especially under evolving standards like EU MDR and IVDR.
Our Expertise in Action:
At MDx, we support companies from prototype to post-market, offering:
- Clinical Strategy & Study Design tailored to AI validation
- Regulatory Roadmapping including software classification, performance evaluation, and CE/FDA submissions
- Risk Management & Documentation in line with ISO 14971, IEC 62304, and GSPR
- Usability Engineering & Human Factors Testing compliant with IEC 62366 and FDA expectations
Post-Market Surveillance (PMS) & PMCF/PMPF Plans for ongoing risk-benefit monitoring
Expertise that Makes a Difference:
Our team has guided software developers through the toughest regulatory transitions and supported numerous Class IIa and Class III SaMD products in gaining CE marking and UKCA certification. With MDx, you don’t just check the regulatory boxes—you build a credible, compliant path to market success.
The Future is Software-Defined
Whether you’re developing AI-based diagnostic tools, clinical decision support systems, or digital therapeutics, MDx CRO is your trusted partner in SaMD innovation. We combine deep technical insight with real-world regulatory experience to help you bring safe, effective, and compliant digital solutions to market—faster.
Let’s talk about your next SaMD project.
Contact us today for a free consultation.
